POET-II Trial Reassesses Antibiotic Duration for Infective Endocarditis

The POET-II trial focuses on re-evaluating the duration of antibiotic therapy for infective endocarditis (IE), a serious and uncommon disease affecting the heart valves. This study specifically addresses left-sided IE, which involves the aortic or mitral valves, aiming to optimize treatment protocols.

Originally published by gnews